P509: CLONAL HEMATOPOIESIS-ASSOCIATED MUTATIONS AS MEASURABLE RESIDUAL DISEASE MARKERS IN ACUTE MYELOID LEUKEMIA PATIENTS FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION. (23rd June 2022) - Bischof, L.; Ussmann, J.; Brauer, D.; Backhaus, D.; Herrmann, L.; Franke, G.-N.; Vucinic, V.; Metzeler, K. H.; Platzbecker, U.; Schwind, S.; Jentzsch, M.